Jupiter Endovascular is a company that specializes in endovascular medicine, with a focus on developing innovative therapies for cardiovascular disease. Their vision is to reimagine therapies for millions of patients, starting with pulmonary embolism. They have a team of experienced leaders and have received FDA approval for a pivotal study of their Vertex Pulmonary Embolectomy System using Endoportal Control.
No recent news for this company.